Sean P. Nolan

Sean P. Nolan

Signal active

President & Chief Executive Officer

Bio

Sean P. Nolan is an accomplished executive with over 24 years of pharmaceutical industry experience that includes leadership roles in building and creating significant value for both publicly held and private companies. He has a broad base of business experience in a multi-national pharmaceutical organization, M&A activities in a small, private equity backed company ($900MM) and in a public biotech company ($8.3B).He created, transformed, and optimized businesses through insightful leadership, strong execution skills, and deep business strategy and operational expertise. He is skilled at building compelling company, functional, and team visions and translating those visions into accomplishments.

Location

Chicago, Illinois, United States, North America

Social

Primary Organization

AveXis

AveXis

Founded

2013

Employees

11-50

Industry

Biotechnology, Health Care, Medical, Genetics

Jobs history

5

Encoded Therapeutics

Chairman

2018 - Current

Affinia Therapeutics

Chairman Of The Board

2019 - Current

InterMune

Executive Vice President and Chief Business Officer

2013 - Current

Taysha Gene Therapies

Board Member

2020 - Current

Encoded Therapeutics

Chairman

Invalid date - Current

Board and Advisor Roles

0

N/A

Invest in regions

Profile Resume

Sean P. Nolan is the President & Chief Executive Officer at AveXis, based in United States, North America. With a background in Biotechnology, Sean P. Nolan has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.

Recommendation from your interest

N/A

Investment portfolio

Sean P. Nolan has made 1 investments. Their Latest investment was Series B - Jaguar Gene Therapy on Apr 13, 2021

Number of investment

1

Number of exits

0

Personal investment

1

Annouced DateOrganization NameFunding RoundMoney Raised
Apr 13, 2021
Jaguar Gene Therapy Jaguar Gene Therapy
Series B - Jaguar Gene Therapy
139.0M

Partner investment

2

Annouced DateOrganization NameFunding RoundInvestor NameMoney Raised
Apr 29, 2020
Taysha Gene Therapies Taysha Gene Therapies
Seed Round - Taysha Gene Therapies
Taysha Gene Therapies Nolan Capital
30.0M
Aug 05, 2020
Taysha Gene Therapies Taysha Gene Therapies
Series B - Taysha Gene Therapies
Taysha Gene Therapies Nolan Capital
95.0M

Exits

0

There is no exit available on this Profile

Invest in industries

Recent Activity

There is no recent news or activity for this profile.